Regulatory Affairs_±¹³» ¹ÙÀÌ¿À±â¾÷

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÎ¹® ´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø
Regulatory Affairs

[´ã´ç¾÷¹«]

1. Regulatory Submission Support
: MFDS ¹× FDA °ü·Ã ÀÓ»ó°³¹ß ´Ü°èÀÇ ±ÔÁ¦ Á¦Ãâ ¹®¼­ Áغñ, °ËÅä, ÀÏÁ¤ °ü¸® ¹× Á¦Ãâ Áö¿ø ¾÷¹«¸¦ ¼öÇàÇÑ´Ù.
2. Clinical Development Regulatory Coordination
: ÀÓ»ó°³¹ß, Clinical Operations, CMC, Nonclinical, Medical µî À¯°üºÎ¼­¿Í Çù¾÷ÇÏ¿©
ÀÓ»ó½ÃÇè°èȹ, º¯°æ, º¸°í ¹× Çã°¡ °ü·Ã ÀÚ·á°¡ ±ÔÁ¦ ¿ä°Ç¿¡ ¸Â°Ô ÁغñµÇµµ·Ï Á¶À²ÇÑ´Ù.
3. MFDS / FDA Regulatory Requirement Review
: MFDS ¹× FDAÀÇ ÀÓ»ó½ÃÇè °ü·Ã ±ÔÁ¤, °¡À̵å¶óÀÎ, ICH guideline µîÀ» °ËÅäÇϰí ÇÁ·ÎÁ§Æ® ÆÀ¿¡ ½Ç¹«Àû guidance¸¦ Á¦°øÇÑ´Ù.
4. Regulatory Documentation Management
: IND/CTA °ü·Ã¹®¼­, briefing package, response document, meeting material, internal tracking document
µî regulatory documentationÀ» ÀÛ¼º¡¤°ËÅ䡤°ü¸®ÇÑ´Ù.
5. Health Authority Communication Support
: ±ÔÁ¦±â°ü ÁúÀÇ, º¸¿Ï ¿äû, meeting preparation µî°ú °ü·ÃÇÏ¿© ³»ºÎ ÀڷḦ ÃëÇÕÇϰí response package Áغñ¸¦
Áö¿øÇÑ´Ù. ÇÊ¿ä ½Ã ±ÔÁ¦±â°ü Ä¿¹Â´ÏÄÉÀÌ¼Ç ½Ç¹«¸¦ º¸Á¶ÇÑ´Ù.
6. Regulatory Intelligence
: MFDS ¹× FDA Áß½ÉÀÇ ±ÔÁ¦ º¯È­, guideline update, submission requirement º¯°æ »çÇ×À» ¸ð´ÏÅ͸µÇϰí
³»ºÎ¿¡ °øÀ¯ÇÑ´Ù.
7. Regulatory Risk Identification
: ÀÓ»ó°³¹ß ÀÏÁ¤ ¹× Á¦Ãâ °èȹ¿¡ ¿µÇâÀ» ÁÙ ¼ö ÀÖ´Â regulatory issue¸¦ »çÀü¿¡ ÆÄ¾ÇÇϰí,
»óÀ§ Ã¥ÀÓÀÚ¿Í ÇÔ²² ´ëÀÀ ¹æ¾ÈÀ» °ËÅäÇÑ´Ù.
8. External Vendor Coordination
: CRO, publishing vendor µî°ú Çù¾÷ÇÏ¿© Á¦ÃâÀÚ·á Áغñ ¹× ÀÏÁ¤ °ü¸®¸¦ Áö¿øÇÑ´Ù.
9. Cross-functional Meeting Support
: ÇÁ·ÎÁ§Æ® ȸÀÇ, regulatory meeting preparation, submission readiness meeting µî¿¡ Âü¿©ÇÏ¿© regulatory
°üÁ¡ÀÇ action itemÀ» Á¤¸®Çϰí follow-upÇÑ´Ù.
10. Internal Process Support
: Regulatory Affairs °ü·Ã SOP, document template, submission tracker µî ³»ºÎ ¾÷¹« ÇÁ·Î¼¼½º °³¼± ¹× ¿î¿µÀ»
Áö¿øÇÑ´Ù.


[±Ù¹«ºÎ¼­ ¹× Á÷±Þ/Á÷Ã¥]

    Á÷±Þ/Á÷Ã¥: Â÷Àå, ºÎÀå

[ÀÚ°Ý¿ä°Ç]

°æ·Â: °æ·Â 10³â¡è
ÇзÂ: ´ëÁ¹ ÀÌ»ó
Á÷¹«±â¼ú: Á¦¾àRA

1) °æ·Â : 
   - Á¦¾à¡¤¹ÙÀÌ¿À ¾÷°è Regulatory Affairs ¶Ç´Â Clinical Regulatory °ü·Ã °æ·Â ¾à 10³â ÀÌ»ó
   - ÀÓ»ó°³¹ß ´Ü°èÀÇ regulatory submission ¹× documentation °æÇè
   - IND/CTA ¹× ÀÓ»ó½ÃÇè °ü·Ã ±ÔÁ¤¿¡ ´ëÇÑ ÀÌÇØ
   - ±¹¹®¡¤¿µ¹® regulatory document ÀÛ¼º ¹× °ËÅä °¡´É
   - À¯°üºÎ¼­¿ÍÀÇ Çù¾÷ ¹× ÀÏÁ¤ °ü¸® ¿ª·®
2) ¿ì´ë»çÇ× :
   - MFDS ÀÓ»ó½ÃÇè °ü·Ã ±ÔÁ¤ ¹× Á¦Ãâ °æÇè
   - FDA IND °ü·Ã Áö½Ä ¶Ç´Â ½Ç¹« °æÇè
   - Ç×¾ÏÁ¦/biologics/oncology clinical development °æÇè
   - eCTD/CTD ¹®¼­ ±¸Á¶ ÀÌÇØ
   - ±ÔÁ¦±â°ü ÁúÀÇ ´ëÀÀÀÚ·á ¹× briefing package Áغñ °æÇè
   - CRO ¹× regulatory consultant Çù¾÷ °æÇè

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷
  • ±Þ¿©Á¶°Ç: ȸ»ç³»±Ô

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > ÃÖÁ¾½É»ç > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    À̷¼­, ÀÚ±â¼Ò°³¼­

Á¢¼ö¹æ¹ý

  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® Á¢¼ö, À̸ÞÀÏ
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

00